Study on the potential diagnostic value of metabolomics changes in different biological fluids for aspiration pneumonia
This study identifies DHEAS, ADIOLS and beta-muricholic acid as promising biomarkers for AP, with the potential to improve early diagnosis and treatment. These findings underscore the clinical value of metabolomics in developing diagnostic tools for AP, facilitating better clinical management and patient outcomes. Further research is required to validate these biomarkers in larger cohorts and explore their mechanistic roles in AP pathophysiology.
Authors
- Hongzhi Gao (ORCID: https://orcid.org/0000-0002-5821-2407)
- Fengyu Lin (ORCID: https://orcid.org/0009-0002-6735-5503)
- Lianghui Chen (ORCID: https://orcid.org/0009-0008-5297-1788)
- Yazhen Chen (ORCID: https://orcid.org/0000-0002-4931-2123)
- Yuqi Liu (ORCID: https://orcid.org/0000-0002-6792-5564)
- Jianbao Wang (ORCID: https://orcid.org/0000-0002-1774-5979)
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1186/s12890-025-03519-x
- Citations
- 2
- Primary Topic
- Dysphagia Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.24
Funders
- Nanjing Medical University
- Fujian Provincial Health Commission